Sensitivity and specificity were evaluated with 168 samples, including 90 SMA patients and 78 non-SMA individuals, and their genotypes of SMN1 were confirmed by MLPA and qPCR. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.